8251 - 8260 of 9131 Results
Title
Year
-
OPENTitle: Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 21Start Page: 3613End Page: 3628Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac035Best OA location URL: https://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddac035/42548512/ddac035.pdfCitation Count: 76
-
OPENTitle: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonismJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 395Issue #:Start Page: 115474End Page: 115474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474Best OA location URL: https://doi.org/10.1016/j.expneurol.2025.115474Citation Count: 0
-
OPENTitle: Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 7Start Page: e0304355End Page: e0304355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0304355Best OA location URL: https://doi.org/10.1371/journal.pone.0304355Citation Count: 14
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 38
-
OPENTitle: Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e0317566End Page: e0317566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0317566Best OA location URL: https://doi.org/10.1371/journal.pone.0317566Citation Count: 2
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 8
-
OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page: 212End Page: 212Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://doi.org/10.1186/s12883-024-03702-3Citation Count: 7
-
OPENTitle: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the artJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 186End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01144-2Best OA location URL: https://doi.org/10.1038/s41746-024-01144-2Citation Count: 40
-
OPENTitle: Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /DJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 11Issue #: 7Start Page: 1715End Page: 1731Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.52078Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.52078Citation Count: 8
-
OPENTitle: SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse modelJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01049End Page: e01049Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01049Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01049Citation Count: 0